Does PEMBROLIZUMAB Cause Skin lesion? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Skin lesion have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.1% of all adverse event reports for PEMBROLIZUMAB.
102
Reports of Skin lesion with PEMBROLIZUMAB
0.1%
of all PEMBROLIZUMAB reports
2
Deaths
35
Hospitalizations
How Dangerous Is Skin lesion From PEMBROLIZUMAB?
Of the 102 reports, 2 (2.0%) resulted in death, 35 (34.3%) required hospitalization, and 4 (3.9%) were considered life-threatening.
Is Skin lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Skin lesion?
SECUKINUMAB (1,909)
ADALIMUMAB (1,507)
METHOTREXATE (1,237)
DUPILUMAB (685)
ETANERCEPT (647)
PREDNISONE (617)
TOFACITINIB (478)
INFLIXIMAB (474)
CYCLOSPORINE (380)
LENALIDOMIDE (369)
Which PEMBROLIZUMAB Alternatives Have Lower Skin lesion Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G